| Michael S Bronze, MD | |
|
825 Ne 10th St, Oupb 4300, Oklahoma City, OK 73104-5417 | |
| (405) 271-3445 | |
| Not Available |
| Full Name | Michael S Bronze |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 42 Years |
| Location | 825 Ne 10th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235199209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 21683 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
eCareSoft, Inc. announced today its new channel partner for Puerto Rico and the Virgin Islands, e-Meds Healthcare Information Solutions. e-Meds will represent eCareSoft's integrated clinical, financial and EHR technology for hospitals.
A biochemical analysis study has discovered a new role for the DNA2 enzyme.
Skin cancer is by far the most common form of cancer and too much exposure to Ultraviolet (UV) radiation increases the risk of skin cancer.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 7 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
eCareSoft, Inc. announced today its new channel partner for Puerto Rico and the Virgin Islands, e-Meds Healthcare Information Solutions. e-Meds will represent eCareSoft's integrated clinical, financial and EHR technology for hospitals.
A biochemical analysis study has discovered a new role for the DNA2 enzyme.
Skin cancer is by far the most common form of cancer and too much exposure to Ultraviolet (UV) radiation increases the risk of skin cancer.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 7 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
eCareSoft, Inc. announced today its new channel partner for Puerto Rico and the Virgin Islands, e-Meds Healthcare Information Solutions. e-Meds will represent eCareSoft's integrated clinical, financial and EHR technology for hospitals.
A biochemical analysis study has discovered a new role for the DNA2 enzyme.
Skin cancer is by far the most common form of cancer and too much exposure to Ultraviolet (UV) radiation increases the risk of skin cancer.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael S Bronze, MD 1122 Ne 13th St, Ori 236, Oklahoma City, OK 73117-1039 Ph: (405) 271-1515 | Michael S Bronze, MD 825 Ne 10th St, Oupb 4300, Oklahoma City, OK 73104-5417 Ph: (405) 271-3445 |
News Archive
eCareSoft, Inc. announced today its new channel partner for Puerto Rico and the Virgin Islands, e-Meds Healthcare Information Solutions. e-Meds will represent eCareSoft's integrated clinical, financial and EHR technology for hospitals.
A biochemical analysis study has discovered a new role for the DNA2 enzyme.
Skin cancer is by far the most common form of cancer and too much exposure to Ultraviolet (UV) radiation increases the risk of skin cancer.
Cell Therapeutics, Inc. today reported exploratory analyses of the data at study completion from the Company's pivotal PIX301 trial of Pixuvri, the first randomized controlled trial in patients with relapsed or refractory, aggressive non-Hodgkin's lymphoma.
› Verified 7 days ago
Evelyn Lorents, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |